The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

James L. Rubenstein

Division of Hematology/Oncology and Helen Diller Comprehensive Cancer Center

University of California-San Francisco

CA 94143

USA

[email]@*.ucsf.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Hematology/Oncology and Helen Diller Comprehensive Cancer Center, University of California-San Francisco, CA 94143, USA. 2007 - 2013
  • University of California, San Francisco, USA. 2008
  • University of California, San Francisco, Division of Hematology/Oncology M1282 Box 1270, 94143, USA. 2006
  • Division of Hematology/Oncology, University of California, San Francisco, USA. 2000 - 2005
  • Division of Hematology/Oncology, Comprehensive Cancer Center, Cancer Research Institute, Department of Neurosurgery, USA. 2003

References

  1. Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Rubenstein, J.L., Li, J., Chen, L., Advani, R., Drappatz, J., Gerstner, E., Batchelor, T., Krouwer, H., Hwang, J., Auerback, G., Kadoch, C., Lowell, C., Munster, P., Cha, S., Shuman, M.A., Damon, L.E. Blood (2013) [Pubmed]
  2. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Rubenstein, J., Ferreri, A.J., Pittaluga, S. Leuk. Lymphoma (2008) [Pubmed]
  3. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. Rubenstein, J.L., Fridlyand, J., Abrey, L., Shen, A., Karch, J., Wang, E., Issa, S., Damon, L., Prados, M., McDermott, M., O'Brien, J., Haqq, C., Shuman, M. J. Clin. Oncol. (2007) [Pubmed]
  4. Gene expression and angiotropism in primary CNS lymphoma. Rubenstein, J.L., Fridlyand, J., Shen, A., Aldape, K., Ginzinger, D., Batchelor, T., Treseler, P., Berger, M., McDermott, M., Prados, M., Karch, J., Okada, C., Hyun, W., Parikh, S., Haqq, C., Shuman, M. Blood (2006) [Pubmed]
  5. Pathology and genetics of primary central nervous system and intraocular lymphoma. Rubenstein, J.L., Treseler, P., O'Brien, J.M. Hematol. Oncol. Clin. North Am. (2005) [Pubmed]
  6. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Rubenstein, J.L., Combs, D., Rosenberg, J., Levy, A., McDermott, M., Damon, L., Ignoffo, R., Aldape, K., Shen, A., Lee, D., Grillo-Lopez, A., Shuman, M.A. Blood (2003) [Pubmed]
  7. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Rubenstein, J., Fischbein, N., Aldape, K., Burton, E., Shuman, M. J. Neurooncol. (2002) [Pubmed]
  8. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Rubenstein, J.L., Kim, J., Ozawa, T., Zhang, M., Westphal, M., Deen, D.F., Shuman, M.A. Neoplasia (2000) [Pubmed]
 
WikiGenes - Universities